[1]
M. Taeb, M. Rahmani, L. Sharifi, and A. Mirshafiey, “The Efficacy of Two Specific Toll-like Receptor 4 Antagonists (G2013 & M2000) in Clinical Inflammatory Disease”, BJHMR, vol. 10, no. 6, pp. 299–318, Jan. 2024.